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Survival of Chlamydia pneumoniae following contact 
with various surfaces 
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Objective: In this,study, the survival and recovery of Chlamydia pneumoniae (Cp) strains TW-183, AR-39, AR-388 and 
CWL-029 were measured after inoculation on glass, stainless steel, FormicaR laminate, paper, fabric and human skin. 
Methods: lnoculum in throat washes from healthy volunteers was applied to  each surface. Samples were taken 
immediately after inoculum application and at specified intervals thereafter to  determine infectivity. 
Results: Infectious Cp was recovered from glass for up to 4 h, from paper and fabric for up to 3 h, from FormicaR laminate 
for up to 2 h, from stainless steel for up to 60 min and from human skin for up to 30 min. Drying of the inoculated area 
had no significant effect on the recovery of infectious Cp. Further experiments demonstrated that infectious Cp could 
be transferred to hands by touching these contaminated surfaces and could be recovered from these hands for up to 
3 min. Addition of albumin, surfactant or phosphatidylcholine had no significant effect on the survival of Cp. 
Conclusions: These results suggest that contact with contaminated surfaces may be a potential mode of transmission 
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of cp. 
Laboratory evidence of Chlamydia pneurnoniae (Cp) 
infection has been demonstrated in approximately 10% 
of community-acquired pneumonia cases [l-31. How- 
ever, the organism has also been associated with 
bronchitis [4,5], asthma [6], reactive arthritis [7] and a 
number of other diseases [8-10]. Recent studies 
provide evidence that Cp infection may play a causal 
role in coronary artery dsease [ll-131, although many 
Cp infections are mild or asymptomatic and may 
therefore remain undiagnosed [14-161. 
Specific antibodes against Cp have been found in 
50 to 95% of the adult populations in many dfferent 
countries of the world [3,17-191. The prevalence of 
Cp-related antibodies in The Netherlands is appmxi- 
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mately 80% in subjects between 20 and 80 years of age, 
and no significant difference is found between men and 
women. These data suggest that most people are 
infected and reinfected with Cp throughout life [3,19]. 
Current evidence suggests that Cp infections spread 
slowly and the case-to-case interval is long. Epidemics 
have been described in Norway, Sweden, Finland and 
the US [5,20-221. 
Although Cp infection is presumed to be spread 
&om person to person, the exact route of transmission 
has not been established. The survival of Cp, albeit 
brief, in small-particle aerosols has been demonstrated 
[23]. This study was carried out to determine whether 
Cp remains infectious in respiratory secretions on 
various surfaces and whether hand contact with these 
contaminated surfaces results in transfer of infectious Cp. 
MATERIALS AND METHODS 
Cell culture 
Buffalo green monkey cells (BGM; PAMM, Veldhoven, 
The Netherlands) were grown as monolayers in plastic 
culture flasks at 35°C with 5% carbon dioxide (Cod in 
a hlly humidified cabinet (Costar Europe Ltd, The 
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Netherlands). The BGM cells were cultured in Eagle 
Minimal Essential Medium (EMEM; Life Technologies 
Ltd, Renfrewshire, Scotland), which contained 10% 
fetal calf serum (Life Technologies Ltd, Renfiewshire, 
Scotland), 1% non-essential amino acids (ICN Bio- 
medicals Inc., Costa Mesa, CA), 10 mg/L gentamicin 
(F'harmachemie, Haarlem, The Netherlands), 25 mg/L 
vancomycin (Eli Lilly, Indianapolis, IN) and 4 mg/L 
amphotericin B (Bristol Myers-Squibb, Epernon, 
France) [24]. 
Chlamydia pneumoniae strains 
Stock cultures of TW-183, AR-39, AR-388 
(Washington Research Foundation, Seattle, WA) and 
CWL-029 (American Type Culture Collection, 
Rockville, MD) were used in this study. BGM cells 
were seeded into 75-cm2 tissue-culture flasks (Costar 
Europe Ltd, The Netherlands) and incubated at 35OC 
with 5% CO2 in a fully humidified cabinet. Cell 
monolayen were examined on the day of inoculation 
for confluency. After inoculation with Cp, tissue- 
culture flasks were centrihged at 900 g at 25°C for 60 
min and subsequently incubated with fresh medmm 
containing 0.6 mg/L cycloheximide (Sigma Chemical 
Company, St Louis, MO). 
After 3 days, the flasks were aspirated and the 
monolayers suspended in 5 mL sucrose-phosphate- 
glutamate buffer (SPG) using a cell scraper (Costar 
Europe Ltd). Tenfold dilutions were made of each stock 
solution, and the titer of Cp was calculated by counting 
the inclusions present in the last dilution. The titer was 
expressed as inclusion-forming units (IFU)/mL. All 
stock solutions were stored at -80 O C  prior to use. The 
final concentration of each sample was 5 x lo8 IFU/mL. 
Table 1 Chlamydia pneumoniae antigen recovery from 
various surfaces 
SuLface 
Glass 
Stainless steel 
FormicaR 
laminate 
Paper 
Fabric 
Human skin 
Chlamydia pneumoniae antigen recovered after: 
15min 30min 60min 120min 18Omin 240min 
44f5  48+13 3 5 f 9  46f13 34f8  28k5 
4 2 f 2  42+4 5 0 f 4  41f6  33f5  3753 
60+4 59510 72+2 61f7  6 0 f 4  5 2 4  
6 1 f 5  66f7  6057 41f10 31+7 52211 
81+3 65+2 65+7 60f6  54f7  57f6  
2 2 f 3  19f3  2023 1923 1723 n.t. 
Chlamydia pneumoniae culture 
BGM cells were seeded onto 24-well tissue-culture 
plates (Costar Europe Ltd) and incubated at 35°C with 
5% C02 in a fully humidified cabinet. All cell mono- 
layers were examined on the day of inoculation for 
confluency. Afier inoculation, the 24-well plates were 
centrihged at 900 g at 25OC for 60 min and sub- 
sequently incubated with fiesh medium containing 
0.6 mg/L cycloheximide. After 3 days, the 24-well 
plates were aspirated and fixed with methanol (Merck, 
Darmstadt, Germany). 
The fixed monolayers were rinsed once with 
phosphate-buffered saline and stained by the 
fluorescent-antibody technique, using Chlamydia genus- 
specific mouse monoclonal antibody @ndly provided 
by J.M. Ossewaarde, National Institute of Public 
Health and Environmental Protection, Bilthoven, The 
Netherlands) as described elsewhere [2]. Rabbit anti- 
mouse immunoglobulin (Ig) labeled with fluorescein 
isothiocyanate (Dako A/S, Glostrup, Denmark) was 
used as a conjugate. Evans blue at 0.05% (Sigma 
Chemical Company, St Louis, MO) was used as a 
counterstain. 
Magic" L i e  Chlamydia immunoassay 
The MagicR Lite chlamydia immunoassay (Ciba 
Corning Diagnostics Corp., Medfield, MA) was used 
for the measurement of antigen recovery at each 
interval. The test is based on a genus-specific chemi- 
luminometric antigen-detection assay, and uses 
constant amounts of acridinium ester-labeled mono- 
clonal anti-Chlamydia1 antibody and polyclonal anti- 
Chlamydia1 antibody covalently coupled to para- 
magnetic particles [25]. The test records antigen 
concentrations as relative light units (RLU)/sec. All 
data are expressed as % compared with RLU found in 
the stock solution used for inoculation. 
Throat washes from healthy volunteers 
These consisted of 10-mL phosphate-buffered saline 
collected as throat washes fiom healthy volunteers. Ten 
throat washes were pooled and stored at -2OOC prior 
to use. 
Recovery and survival of Chlamydia pneumoniae from 
various surfaces 
The surfaces used were FormicaR laminate, glass, 
stainless steel, fabric, paper and human skin (fingertips). 
A 5 pL inoculum (2.0 X lo7 IFU/mL) in pooled throat 
washes from healthy volunteers was applied to each 
surface. FormicaR laminate, glass, stainless steel and 
human skin were sampled with a wet swab that was 
were rinsed with 1 mL SPG, and a 100 pL sample was 
n.t. = not tested. 
The data are presented as mean %+SE antigen recovered by 
MagicR Lite Chlamydia immunoassay, whch reports antigen 
concentrations as relative light units (RLLJ)/sec. 
with four different strains of C. pneumoniae). 
All data are expressed as % compared with RLU in the stock 
solution used for inoculation (average of three separate experiments subsequently suspended in mL SPG' Fabric and paper 
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used to inoculate cell monolayers to determine the 
infectivity (as described above). The MagicR Lite 
Chlamydia immunoassay was used to calculate the 
recovery of Cp antigen, using a 200 pL sample for 
the detection of Cp antigen as described by the 
manufacturer. Samples were taken immediately after 
inoculum application and at specified intervals 
thereafter. Temperature and humidlty were monitored 
and maintained at 22 to 28OC and 40 to 60% relative 
humidity. 
Effect of additives on Survival of Chlamydia pneumoniae 
on various surfaces 
Human serum albumin at 50 mg/L (The Netherlands 
Red Cross Blood Transhsion Service, Amsterdam, 
The Netherlands), surfactant at 34mg/L (lundly 
provided by J.E van Iwaarden, Laboratory of Veterinary 
Biochemistry, University of Utrecht, The Netherlands) 
and phosphatidylcholine at 1.2 mg/L (Sigma Chemical 
Company, St. Louis, MO) was added to the inoculum 
prior to contamination of the various test surfaces. 
100 1 
incubation (minutes) 
Figure 1 Mean % Cp survival and antigen recovery 
following contact with glass (m), FormicaRlaminate (O), 
paper (e), fabric to), stainless steel (A) and human skin 
(0). The data represent the average of four separate 
experiments with four different C. pneumoniae strains). 
Recovery of infectious Ch/amydia pneumniae from human 
skin alter transfer from environmental surfaces 
A 5 p L  inoculum (2.0 X lo7 IFU/mL) was ahnistered 
to a glass surface. Samples were taken &om hands after 
having touched the contaminated surface and were 
cultured as described above. 
RESULTS 
Antigen recovery 
The average rate of recovery of Cp antigen after 
Cp contamination (Table 1) &om glass, stainless steel, 
FormicaR laminate and paper at 15 min was 44%, 42%, 
60% and 61%, respectively, compared with 81% and 
22% from fabric and human skin, respectively. The 
antigen recovery was significantly lower h m  human 
skin compared with the other surfaces tested (p <0.05). 
The Cp-antigen recovery rate remained constant over 
time on all surfaces; drylng of the inoculated area had 
no signrficant effect on Cp-antigen recovery, and no 
sigruficant differences were found among the four Cp 
isolates. 
Survival of Chlamydia pneumoniae following contact with 
various surfaces 
Infectious Cp was recoverable h m  FormicaR laminate 
and human skin for up to 120 and 30 min, respectively 
(Figure 1). Drying of the inoculated area had no 
significant effect on Cp suMval. After 15 min, the 
recovery of infectious Cp from FormicaR larmnate was 
1.8X lo4 IFU whereas, on human slun, the suMval rate 
was only 2.9X lo3  IFU (68% and 31% compared with 
to, respectively). In contrast, recovery of Cp antigen 
&om these surfaces was stable over the time period 
sampled, as determined by the Magi? Lite Chlamydia 
assay (Table 1). 
Infectious Cp was recoverable from glass, paper, 
fabric and stainless steel for up to 240, 180, 180 and 
120 min, respectively. After 15 min, recovery of 
infectious Cp was 1.7X104, 2.1X104, 3.2X104 and 
1.4X104 IFU on the respective surfaces (81%, 78%, 
86% and 71%, respectively, compared with to).  Cp 
survival on stainless steel was of significantly shorter 
duration compared with glass and FormicaR laminate 
(p<O.O5; data not shown). 
No significant differences in survival and antigen 
recovery were found among the four Cp strains tested, 
nor did the addition of albumin, surfactant or phospha- 
tidylcholine have significant effects on the survival and 
recovery of Cp on any of the surfaces tested (data not 
shown). 
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Recovery of Chlamydiapneumoniae from human skin after 
transfer from environmental surfaces 
Cp was recoverable from hands that had touched the 
contaminated glass, although recovery of infectious 
Cp was restricted to the first 3 min following contact 
vc;ith the contaminated area. The average recovery of 
infectious Cp from fingertips after 1 and 3 min was 580 
(6%) and 96 (1%) IFU, respectively. No infectious Cp 
or Cp antigen was recovered if hands were washed with 
soap and water prior to sampling. 
DISCUSSION 
Chlamydia pneumoniae is considered an important 
pathogen associated with approximately 10% of pneu- 
monia cases and other respiratory infections [l-31. 
Many Cp infections are mild or asymptomatic and may 
therefore remain undiagnosed [ 14-16]. However, the 
recent association of Cp with coronary artery dsease 
has prompted a reevaluation of the pathogenesis of Cp 
infection in patients [ll-131. The high prevalence of 
Cp-specific antibodies among Dutch adults indicates 
the possibility of reinfection. However, little is known 
of the mode of transmission of this organism. Survival 
of Cp in small-particle aerosols is possible, especially at 
relatively high humidities, but the duration is relatively 
short [23]. 
One study of the survival of Cp following contact 
with environmental surfaces has been described by 
other investigators [26] in contrast to the many survival 
studies with respiratory viruses. The feasibility of the 
spread of rhinoviruses and respiratory syncytial virus 
(RSV) has been well documented [27,28]. Investigators 
have demonstrated that rhinovirus transmission is 
mostly by hand contact with contaminated surfaces 
and occasionally afier large-particle exposure, but not 
following small-particle exposure [27]. Transmission of 
RSV infection is also possible through indirect contact 
with contaminated surfaces [29]. 
In the present study of Cp survival and trans- 
mission, a theoretical chain of several steps was 
examined, starting with Cp-antigen recovery from 
various surfaces, which remained constant over time on 
all surfaces. Drying of the inoculated area had no 
significant effect on antigen recovery. A significantly 
lower recovery was observed from human skin com- 
pared with the other surfaces tested. One possible 
explanation for this phenomenon may be an increased 
adherence of the microorganism to the surface of 
human skin. 
The survival of Cp on various surfaces lasted for 
long periods of time and was transferable to hands. 
Drying of the inoculated area had no significant effect 
on the rate of survival, which was apparently poorer on 
human skin and stainless steel than on the other surfaces 
tested. One reason for the significantly reduced survival 
on human skin may be the presence of lactic acid, 
which causes the pH of skin to be acid. Also, the 
presence of skin surface lipids and excretory products 
of the resident microbiological flora may limit the 
survival of Cp on human skin [30]. Addition of 
albumin, surfactant or phosphatidylcholine, however, 
had no effect on the survival time of Cp. The reason 
for the short survival on stainless steel is unexplained. 
An antimicrobial action of ferrous ions may be one 
explanation for the accelerated inactivation of Cp. 
Infectious Cp was recoverable from hands, but only 
during the first 3 min following contact with surfaces 
contaminated with Cp. No significant differences were 
found among the four Cp strains used in this study. 
Falsey and Walsh have compared the survival of Cp 
after contact with human skin, tissue and FormicaR 
laminate [26], and the results of the present study are 
comparable to their findings. However, discrepant 
results are found with FormicaR laminate: Falsey and 
Walsh reported a survival period of up to 30 h, which 
is significantly longer than the 3-h survival in the 
present study. Such a significant difference may be the 
result of substantial differences in methodology. In the 
present study, a 5 pL. Cp-stock suspension was applied 
to each surface tested whereas Falsey and Walsh used 
100 $. Also, in our study, the Cp-stock suspensions 
were diluted in pooled throat washes from healthy 
volunteers prior to sampling whereas SPG was used by 
Falsey and Walsh. In our opinion, the use of small 
sample volumes that were diluted in human pooled 
throat washes is closer to reality. 
In conclusion, the results of the present study 
inhcate that Cp is able to survive sufficiently long in 
the environment to allow transfer of infectious Cp to 
hands in contact with contaminated surfaces. As with 
many respiratory viruses, this may be the most efficient 
route of transmission of these microorganisms. 
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